High level of industry engagement in MMI CTRSP

UK Clinical Research Facility Network Conference 2012
July 19, 2012
MMI Scholars benefit from placements in Clinical Research Facilities in Cork, Dublin and Galway
August 4, 2012
Show all

High level of industry engagement in MMI CTRSP

Molecular Medicine Ireland is delighted with the response to our request for industry and commercially relevant work placements for students on the MMI Clinical & Translational Research Scholars Programme.

Over 20 organisations are offering a variety of 10-15 week placement experiences in the clinical and translational research environment. These include biomarker assay development; medical device and diagnostic product R&D; preparing pre-clinical and clinical protocols; identification and validation of therapeutic targets; developing disease models; clinical validation activities; characterisation of therapeutic bacterial strains; design analysis and reporting of observational research studies and clinical trials; pharmacovigilance quality and regulatory affairs; high content screening technology development; pharmaceutical marketing; Clinical Research Organisation R&D.

Placement providers are distributed across the enterprise sector with a translational medicine/technology focus including biomedical start-ups medical device companies clinical research organisations and multinational pharmaceutical companies. We would like to acknowledge this high level of industry engagement for a single structured PhD programme with the following organisations providing work placements: Abbott Alimentary Health Alimentary Pharmabiotic Centre (project developed with industry partner) A. Menarini Pharmaceuticals Amgen Argutus Medical Biosensia BlueBridge Technologies Boston Scientific Cellix Creganna-Tactx Medical Crospon Irish National Centre for High Content Screening & Analysis (spin-out of technologies) Janssen Java Clinical Research Medtronic Merck Neuravi Oncomark Sanofi Sigmoid Pharma Trinity Biotech UCB Veryan. In addition the Irish Medicines Board are providing a valuable placement in the regulatory environment.

We look forward to developing collaborations of mutual benefit with all our partners in this unique structured PhD programme funded through the Irish Government’s PRTLI Cycle 5.

The Molecular Medicine Ireland Clinical & Translational Research Scholars Programme (CTRSP) is a new 4-year structured PhD programme for science graduates. The length of four years provides a full year before students begin their PhD research projects in which we are providing short taught courses academic lab placements a placement in an academic clinical research facility and an industry placement.

The 20 MMI Scholars recruited to the CTRSP last year have undergone a rigorous selection process in which they were assessed by panels including industry representatives. Five students are based in each of the academic partners; NUI Galway Trinity College Dublin University College Cork and University College Dublin. During the first months of their PhD students have participated in an intensive series of taught courses in mechanisms of disease pharmacology imaging technologies communication skills and research ethics plus laboratory and clinical research facility placements.

MMI and its partner academic institutions have come together with the aim to create a training programme that equips graduates with skills to build careers in industry as well as in academic patient-focused research. Industry is fundamentally involved in design and governance of the CTRSP together with the Irish Medicines Board. MMI Scholars begin their industry placements in May. Our industry partners will continue to engage with MMI Scholars throughout their PhD studies as external mentors providing advice on developing transferable skills for career progression.

The MMI Clinical & Translational Research Scholars Programme is funded under the Programme for Research in Third Level Institutions (PRTLI) Cycle 5 and co-funded under the European Regional Development Fund (ERDF).